UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 腎移植における哺乳動物ラパマイシン標的蛋白質（mTOR）阻害剤 mammalian target of rapamycin mtor inhibitors in renal transplantation
- 2. 成人肝移植における免疫抑制の概要 overview of immunosuppression in adult liver transplantation
- 3. 肺移植後の免疫抑制の維持 maintenance immunosuppression following lung transplantation
- 4. 成人腎移植レシピエントの診療の概要 overview of care of the adult kidney transplant recipient
- 5. 結節性硬化症：管理 tuberous sclerosis complex management
English Journal
- Sirolimus for refractory vascular anomalies.
- Trenor CC 3rd.SourceDivision of Hematology/Oncology, Vascular Anomalies Center, Children's Hospital Boston and Dana-Farber Cancer Institute, 300 Longwood Avenue, Boston, Massachusetts 02115. Cameron.trenor@childrens.harvard.edu.
- Pediatric blood & cancer.Pediatr Blood Cancer.2011 Dec 1;57(6):904-5. doi: 10.1002/pbc.23178. Epub 2011 Apr 29.
- PMID 21538825
- Sirolimus for the treatment of complicated vascular anomalies in children.
- Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM.SourceHemangioma and Vascular Malformation Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio. adrienne.hammill@cchmc.org.
- Pediatric blood & cancer.Pediatr Blood Cancer.2011 Dec 1;57(6):1018-24. doi: 10.1002/pbc.23124. Epub 2011 Mar 28.
- BACKGROUND: Vascular anomalies comprise a diverse group of diagnoses. While infantile hemangiomas are common, the majority of these conditions are quite rare and have not been widely studied. Some of these lesions, though benign, can impair vital structures, be deforming, or even become life-threate
- PMID 21445948
Japanese Journal
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection : a randomised multicentre study. The Rapamune US Study Group
- KAHAN BD.
- Lancet 356, 194-202, 2000
- NAID 30005705157
- Rapamune (RAPA, rapamycin, sirolimus) : mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
- SEHGAL S. N.
- Clinical Biochem. 31(5), 335-340, 1998
- NAID 80010516856
Related Links
- RAPAMUNE has not been shown to be safe and effective in people who have had liver or lung transplants. Serious complications and death may happen in people who take RAPAMUNE after a liver or lung transplant. You should not take ...
Related Pictures
★リンクテーブル★
| リンク元 | 「シロリムス」 |
「シロリムス」
-sirolimus
-ラパマイシン